Back to JNJ
Livforsakringsbolaget Skandia, Omsesidigt → JNJ
Livforsakringsbolaget Skandia, Omsesidigt JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
9
Latest value
$54.6M
Q3 2026
Peak value
$54.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.3M |
| Q3 2025 | $32.9M |
| Q4 2025 | $3.5M |
| Q1 2026 | $4.1M |
| Q1 2026 | $47.7M |
| Q2 2026 | $4M |
| Q2 2026 | $52.4M |
| Q3 2026 | $2.6M |
| Q3 2026 | $54.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $54.6M | 206.3K | — | — |
| Q3 2026 | $2.6M | 9.7K | — | — |
| Q2 2026 | $52.4M | 206.3K | — | — |
| Q2 2026 | $4M | 15.9K | — | — |
| Q1 2026 | $47.7M | 195.1K | — | — |
| Q1 2026 | $4.1M | 16.7K | — | — |
| Q4 2025 | $3.5M | 16.7K | — | — |
| Q3 2025 | $32.9M | 177.4K | — | — |
| Q3 2025 | $3.3M | 17.9K | — | — |
Other funds holding JNJ
$44.8B
$39.6B
$34.5B
$32.6B
$27.7B